Next-Generation Leaders of K-Bio Put to the Test at JPMorgan As owner heirs of major Korean biotech companies took center stage at the JPMorgan Healthcare Conference (JPMHC)—the world’s largest pharmaceutical and biotech

According to industry sources, owner successors of leading Korean biotech firms drew significant attention as they stepped forward at the 44th JPMorgan Healthcare Conference held recently in San Francisco.
#JPMorgan #JPMHC #Celltrion #Lotte #SK #bio #it #itchosun #chosun #SouthKorea #Korea

Overview: Hacker News debated the J.P. Morgan Healthcare Conference. Many questioned its true value, noting a stark contrast between formal talks and crucial informal networking & deal-making happening outside. Comments were often witty and cynical about industry gatherings. #JPMHC 1/6

Lessons from #JPMHC 2025 must include the opportunity for medical tourism. Patients who cannot get surgery, pharma products, or assistive devices in their own countries will travel to places where they can get such support.

The #JPMHC 2025 in San Francisco is wrapping up today. I sense that public discussion of upcoming regulatory changes was understated. Prepare for changes to longstanding business models in healthcare.

I am ready for the #JPMHC 2025 in San Francisco this week. Healthcare and biotech innovation are paths to bonanza.